- ISIN
- JP3546800008
- CUSIP
- 88156J105
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
Highlights
- Market Cap
- $21.57B
- Enterprise Value
- $23.93B
- EPS (TTM)
- ¥92.59
- PE Ratio
- 25.51
- PEG Ratio
- 2.07
- Total Revenue (TTM)
- ¥1.14T
- Gross Profit (TTM)
- ¥597.85B
- EBITDA (TTM)
- ¥280.94B
- Year Range
- $11.49 - $20.46
- ROA (TTM)
- 5.87%
- ROE (TTM)
- 8.57%
Share Price Chart
Loading charts...
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
TRUMF Performance Chart
Terumo Corporation (TRUMF) is up 11.8% since the beginning of the year. At $15 per share, TRUMF is trading 28.6% below its 52-week high of $20. Investors who bought $1,000 worth of TRUMF shares 5 years ago would now be looking at an investment worth $756.
Loading charts...
Returns By Period
Terumo Corporation (TRUMF) has returned 11.83% so far this year and -8.56% over the past 12 months. Over the last ten years, TRUMF has returned 3.96% per year, falling short of the S&P 500 Index benchmark, which averaged 13.88% annually.
Terumo Corporation
- 1D
- 0.00%
- 1M
- 26.06%
- YTD
- 11.83%
- 6M
- -1.44%
- 1Y
- -8.56%
- 3Y*
- -2.06%
- 5Y*
- -5.45%
- 10Y*
- 3.96%
Benchmark (S&P 500 Index)
- 1D
- -0.37%
- 1M
- -0.01%
- YTD
- 9.16%
- 6M
- 8.64%
- 1Y
- 25.22%
- 3Y*
- 19.78%
- 5Y*
- 11.99%
- 10Y*
- 13.88%
TRUMF Monthly Returns History
Based on dividend-adjusted daily data since Aug 7, 2007, TRUMF's average daily return is +0.06%, while the average monthly return is +0.63%. At this rate, an investment would double in approximately 9.2 years.
Historically, 51% of months were positive and 49% were negative. The best month was Nov 2008 with a return of +25.2%, while the worst month was Apr 2014 at -54.7%. The longest winning streak lasted 7 consecutive months, and the longest losing streak was 4 months.
On a daily basis, TRUMF closed higher 20% of trading days. The best single day was May 26, 2026 with a return of +27.5%, while the worst single day was Apr 2, 2014 at -50.9%.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | 4.65% | -7.54% | -2.14% | 6.64% | 14.58% | -3.34% | 11.83% | ||||||
| 2025 | 4.17% | -11.30% | -2.33% | 19.51% | -8.97% | -1.86% | -2.64% | 9.35% | -22.93% | -1.45% | 17.35% | -24.06% | -30.58% |
| 2024 | 6.28% | 12.58% | -2.24% | -6.23% | -4.75% | -1.12% | 1.57% | 19.46% | 0.12% | -7.17% | 17.38% | -11.15% | 21.51% |
| 2023 | 0.68% | -7.95% | 2.33% | 10.74% | -0.46% | 6.76% | 0.54% | -7.32% | -8.80% | 0.78% | 17.76% | -0.99% | 11.43% |
| 2022 | -14.20% | -12.76% | -3.22% | -1.00% | 5.49% | -7.38% | 15.82% | -5.59% | -13.94% | 7.60% | -4.62% | 1.02% | -31.64% |
| 2021 | -7.28% | -5.01% | -1.69% | 4.65% | 1.35% | 4.60% | -2.24% | 4.56% | 16.71% | -8.84% | -6.62% | 3.05% | 0.53% |
Benchmark Metrics
Terumo Corporation has an annualized alpha of 13.82%, beta of 0.09, and R2 of 0.00 versus S&P 500 Index. Calculated based on daily prices since August 07, 2007.
- This stock participated in 82.31% of S&P 500 Index downside but only 55.16% of its upside - more exposed to losses than it benefited from rallies.
- Beta of 0.09 may look defensive, but with R2 of 0.00 this stock is largely uncorrelated with S&P 500 Index - low beta reflects independence, not downside protection. See the Volatility section for a true picture of this stock's risk.
- R2 of 0.00 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.
- Alpha
- 13.82%
- Beta
- 0.09
- R²
- 0.00
- Upside Capture
- 55.16%
- Downside Capture
- 82.31%
Return for Risk
Risk / Return Rank
TRUMF ranks 42 for risk / return — on par with similar stocks. You're getting a typical balance of risk and reward. Not a standout, but not a red flag either — a reasonable choice if other factors align with your goals.
Return / Risk — by metrics
The table below present risk-adjusted performance metrics for Terumo Corporation (TRUMF) and compare them to S&P 500 Index.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| TRUMF | Benchmark | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -2.11 | ||
| Sortino ratioReturn per unit of downside risk | -2.06 | ||
| Omega ratioGain probability vs. loss probability | 1.09 | 1.37 | -0.28 |
| Calmar ratioReturn relative to maximum drawdown | -0.20 | 2.78 | -2.99 |
| Martin ratioReturn relative to average drawdown | -0.32 | 12.44 | -12.76 |
Dividends
Dividend History
Terumo Corporation provided a 1.33% dividend yield over the last twelve months, with an annual payout of $0.19 per share. The company has been increasing its dividends for 3 consecutive years.
| Period | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend | $0.19 | $0.19 | $0.16 | $0.15 | $0.13 | $0.13 | $0.13 | $0.07 | $0.11 | $0.05 | $0.04 |
Dividend yield | 1.33% | 1.41% | 0.85% | 0.96% | 0.88% | 0.62% | 0.62% | 0.37% | 0.83% | 0.40% | 0.51% |
Monthly Dividends
The table displays the monthly dividend distributions for Terumo Corporation. The dividends shown in the table have been adjusted to account for any splits that may have occurred.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | $0.00 | $0.00 | $0.09 | $0.00 | $0.00 | $0.00 | $0.09 | ||||||
| 2025 | $0.00 | $0.00 | $0.09 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.10 | $0.00 | $0.00 | $0.00 | $0.19 |
| 2024 | $0.00 | $0.00 | $0.07 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.09 | $0.00 | $0.00 | $0.00 | $0.16 |
| 2023 | $0.00 | $0.00 | $0.08 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.07 | $0.00 | $0.00 | $0.00 | $0.15 |
| 2022 | $0.00 | $0.00 | $0.07 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.06 | $0.00 | $0.00 | $0.00 | $0.13 |
| 2021 | $0.00 | $0.00 | $0.06 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.07 | $0.00 | $0.00 | $0.00 | $0.13 |
Dividend Yield & Payout
Dividend Yield
Terumo Corporation has a dividend yield of 1.33%, which signifies it pays a smaller percentage of its stock price in dividends to its shareholders compared to other companies in the market.
Payout Ratio
Terumo Corporation has a payout ratio of 30.24%, which is quite average when compared to the overall market. This suggests that Terumo Corporation strikes a balance between reinvesting profits for growth and paying dividends to shareholders.
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading charts...
Worst Drawdowns
The table below displays the maximum drawdowns of the Terumo Corporation. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Terumo Corporation was 65.24%, occurring on Apr 25, 2014. Recovery took 984 trading sessions.
The current Terumo Corporation drawdown is 38.65%.
Related event | Drawdown | Fall | Recovery | Underwater |
|---|---|---|---|---|
2014 bear market2014 | -65.24%Apr 2014 | 3y 3mo | 3y 12mo | 7y 3moJan 2011 - Apr 2018 |
2026 bear market2026 | -51.78%May 2026 | 4y 7mo | — | 4y 8moSep 2021 - now |
Financial crisis2007–2009 | -41.07%Oct 2008 | 8mo 26d | 1y 3mo | 1y 11moFeb 2008 - Jan 2010 |
COVID crash2020 | -25.89%Mar 2020 | 1mo 18d | 2mo 12d | 4moJan 2020 - May 2020 |
2021 correction2021 | -19.57%Mar 2021 | 1mo 11d | 5mo 12d | 6mo 23dFeb 2021 - Sep 2021 |
Drawdown Indicators
| TRUMF | Benchmark | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -65.24% | -56.78% | -8.46% |
Max Drawdown (1Y)Largest decline over 1 year | -42.32% | -9.10% | -33.22% |
Max Drawdown (3Y)Largest decline over 3 years | -45.78% | -18.90% | -26.88% |
Max Drawdown (5Y)Largest decline over 5 years | -51.78% | -25.43% | -26.35% |
Max Drawdown (10Y)Largest decline over 10 years | -51.78% | -33.92% | -17.86% |
Current DrawdownCurrent decline from peak | -38.65% | -1.80% | -36.85% |
Average DrawdownAverage peak-to-trough decline | -22.97% | -10.71% | -12.26% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 26.86% | 2.03% | +24.83% |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading charts...
Financials
Financial Performance
The chart below illustrates the trends in the financial health of Terumo Corporation over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.
Valuation
The Valuation section provides an overview of how Terumo Corporation is priced in the market compared to other companies in the Medical Instruments & Supplies industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.
PE Ratio
The chart displays the Price-to-Earnings (P/E) ratio for TRUMF, comparing it with other companies in the Medical Instruments & Supplies industry. Currently, TRUMF has a P/E ratio of 25.5. This P/E ratio is in line with the industry average, suggesting the stock may be fairly valued relative to its earnings.
PEG Ratio
The chart shows the Price/Earnings to Growth (PEG) ratio for TRUMF compared to other companies in the Medical Instruments & Supplies industry. TRUMF currently has a PEG ratio of 2.1. This PEG ratio is close to the industry average, suggesting the stock’s valuation is balanced against its growth outlook.
PS Ratio
This chart shows the Price-to-Sales (P/S) ratio for TRUMF relative to other companies in the Medical Instruments & Supplies industry. Currently, TRUMF has a P/S ratio of 3.1. This P/S ratio falls within the average range for the industry, suggesting the stock is fairly valued based on its revenue.
PB Ratio
The chart illustrates the Price-to-Book (P/B) ratio for TRUMF in comparison with other companies in the Medical Instruments & Supplies industry. Currently, TRUMF has a P/B value of 2.2. This P/B ratio is in line with the industry average, suggesting the stock is valued fairly in relation to its book value.
Income Statement
| TTM | |
|---|---|
Revenue | — |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | — |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | — |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |
Build a portfolio with TRUMF
Add Terumo Corporation to a portfolio and analyze allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Analyzer with TRUMF